<!DOCTYPE html>
<!-- Generated by pkgdown: do not edit by hand --><html lang="en">
<head>
<meta http-equiv="Content-Type" content="text/html; charset=UTF-8">
<meta charset="utf-8">
<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no">
<title>Interventions • site</title>
<script src="../deps/jquery-3.6.0/jquery-3.6.0.min.js"></script><meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no">
<link href="../deps/bootstrap-5.3.1/bootstrap.min.css" rel="stylesheet">
<script src="../deps/bootstrap-5.3.1/bootstrap.bundle.min.js"></script><link href="../deps/font-awesome-6.5.2/css/all.min.css" rel="stylesheet">
<link href="../deps/font-awesome-6.5.2/css/v4-shims.min.css" rel="stylesheet">
<script src="../deps/headroom-0.11.0/headroom.min.js"></script><script src="../deps/headroom-0.11.0/jQuery.headroom.min.js"></script><script src="../deps/bootstrap-toc-1.0.1/bootstrap-toc.min.js"></script><script src="../deps/clipboard.js-2.0.11/clipboard.min.js"></script><script src="../deps/search-1.0.0/autocomplete.jquery.min.js"></script><script src="../deps/search-1.0.0/fuse.min.js"></script><script src="../deps/search-1.0.0/mark.min.js"></script><!-- pkgdown --><script src="../pkgdown.js"></script><meta property="og:title" content="Interventions">
</head>
<body>
    <a href="#main" class="visually-hidden-focusable">Skip to contents</a>


    <nav class="navbar navbar-expand-lg fixed-top bg-light" data-bs-theme="light" aria-label="Site navigation"><div class="container">

    <a class="navbar-brand me-2" href="../index.html">site</a>

    <small class="nav-text text-muted me-auto" data-bs-toggle="tooltip" data-bs-placement="bottom" title="">1.0.6</small>


    <button class="navbar-toggler" type="button" data-bs-toggle="collapse" data-bs-target="#navbar" aria-controls="navbar" aria-expanded="false" aria-label="Toggle navigation">
      <span class="navbar-toggler-icon"></span>
    </button>

    <div id="navbar" class="collapse navbar-collapse ms-3">
      <ul class="navbar-nav me-auto">
<li class="nav-item"><a class="nav-link" href="../reference/index.html">Reference</a></li>
<li class="active nav-item dropdown">
  <button class="nav-link dropdown-toggle" type="button" id="dropdown-articles" data-bs-toggle="dropdown" aria-expanded="false" aria-haspopup="true">Articles</button>
  <ul class="dropdown-menu" aria-labelledby="dropdown-articles">
<li><a class="dropdown-item" href="../articles/Accessing-site-files.html">Accessing site-files</a></li>
    <li><a class="dropdown-item" href="../articles/historical_epi.html">Historical Epidemiological Data</a></li>
    <li><a class="dropdown-item" href="../articles/Interventions.html">Interventions</a></li>
    <li><a class="dropdown-item" href="../articles/Metadata.html">Metadata</a></li>
    <li><a class="dropdown-item" href="../articles/pop_demog.html">Population and Demography</a></li>
    <li><a class="dropdown-item" href="../articles/Seasonality.html">Seasonality</a></li>
    <li><a class="dropdown-item" href="../articles/vectors.html">Mosquito Vectors</a></li>
  </ul>
</li>
<li class="nav-item"><a class="nav-link" href="../news/index.html">Changelog</a></li>
      </ul>
<ul class="navbar-nav">
<li class="nav-item"><form class="form-inline" role="search">
 <input class="form-control" type="search" name="search-input" id="search-input" autocomplete="off" aria-label="Search site" placeholder="Search for" data-search-index="../search.json">
</form></li>
      </ul>
</div>


  </div>
</nav><div class="container template-article">




<div class="row">
  <main id="main" class="col-md-9"><div class="page-header">

      <h1>Interventions</h1>
            
      

      <div class="d-none name"><code>Interventions.Rmd</code></div>
    </div>

    
    
<p><code>site_file$interventions</code></p>
<p>Interventions contains the historical intervention information for a
site. It is also the section of the site file that you would modify with
intervention information for future scenarios. Details, references and
methods for individual interventions are shown below:</p>
<div class="section level2">
<h2 id="itns">ITNs<a class="anchor" aria-label="anchor" href="#itns"></a>
</h2>
<div class="section level3">
<h3 id="itn-use">ITN use<a class="anchor" aria-label="anchor" href="#itn-use"></a>
</h3>
<p><code>site_file$interventions$itn_use</code></p>
<p>Due to differences in the availability of data sources the approach
for countries within sub-Saharan Africa differs to countries outside of
sub-Saharan Africa:</p>
<div class="section level4">
<h4 id="within-sub-saharan-africa">Within sub-Saharan Africa<a class="anchor" aria-label="anchor" href="#within-sub-saharan-africa"></a>
</h4>
<p>The population at risk weighted mean ITN use estimates for each site
are taken from the malaria atlas project raster entitled:
“Interventions__202406_Africa_Insecticide_Treated_Net_Use”. This, and
other elements of the <a href="https://mrc-ide.github.io/netz/" class="external-link">netz R
package</a> are based on work by Bertozzi-Villa <em>et al</em><span class="citation"><sup><a href="#ref-bertozzi">1</a></sup></span></p>
</div>
<div class="section level4">
<h4 id="outside-of-sub-saharan-africa">Outside of sub-Saharan Africa<a class="anchor" aria-label="anchor" href="#outside-of-sub-saharan-africa"></a>
</h4>
<p>ITN use is much more heterogeneous outside of SSA and data are less
systematically collected. As a result, there are strong assumptions
associated with the historical scale and magnitude of ITN distributions.
We make the assumption that any reported ITN distributions (as detailed
by the world malaria report<span class="citation"><sup><a href="#ref-WMR">2</a></sup></span>) are targeted such that areas with
the highest baseline prevalence are prioritised first. Net use is<br>
implemented up to a maximum usage of 55% in each area, sequentially
working through the targeting until the reported total number of bed
nets have been allocated.</p>
</div>
</div>
<div class="section level3">
<h3 id="missing-years">Missing years<a class="anchor" aria-label="anchor" href="#missing-years"></a>
</h3>
<p>Available data on ITN use (via MAP<span class="citation"><sup><a href="#ref-MAP">3</a></sup></span> or the world malaria report @ WMR)
will not extend to the present year. Missing ITN use estimates to
present are filled assuming a constant, continuing level of coverage. To
respect the multi-year cyclical nature of ITN distribution cycles any
missing estimates are filled in assuming that coverage is constant with
respect to 3 years prior. For example if years 2019, 2020 and 2021 are
missing then 2019 == 2016, 2020 == 2017 and 2021 == 2018.</p>
</div>
<div class="section level3">
<h3 id="net-type">Net type<a class="anchor" aria-label="anchor" href="#net-type"></a>
</h3>
<p><code>site_file$interventions$net_type</code></p>
<p>Net type introductions are informed by data from alliance for malaria
prevention<span class="citation"><sup><a href="#ref-alliance">4</a></sup></span>. Current available net types
are: pyrethroid_only, pyrethroid_pbo and pyrethroid_pyrrole.</p>
</div>
<div class="section level3">
<h3 id="net-input-distribution">Net input distribution<a class="anchor" aria-label="anchor" href="#net-input-distribution"></a>
</h3>
<p><code>site_file$interventions$itn_input_dist</code></p>
<p>Modelling Bed Net Use in the Malaria Model</p>
<p><strong>Observed data</strong> Each year, we obtain an estimate of
the population-level usage of bed nets from available data. This time
series represents the proportion of the population reported to be using
bed nets annually.</p>
<p><strong>Model requirement</strong> To incorporate these observations
into the model, we calculate the yearly coverage inputs that align with
the observed usage. These inputs represent the distribution of nets that
ultimately result in the reported usage levels.</p>
<p><strong>Accounting for net retention</strong> Bed nets distributed in
a given year remain in use for multiple years, with their effective
coverage diminishing over time. Consequently, the observed usage in any
given year reflects not only the nets distributed that year but also the
cumulative contribution of nets distributed in previous years.</p>
<p><strong>Back-calculation of coverage inputs</strong> The model uses
the observed usage time series to reverse-engineer the yearly net
distributions required to produce the observed patterns. This
calculation incorporates estimates of net retention (how long nets are
expected to last after being distributed) from<span class="citation"><sup><a href="#ref-bertozzi">1</a></sup></span>, that
are adjusted malariasimulation assumes an exponential decay on net
retention, whilst the estimates are from a model assuming a sigmoidal
decay.</p>
<p><strong>Capturing population-level dynamics</strong> By combining
distribution events from multiple years and their overlapping effects,
the model accounts for the cumulative build-up of nets in the
population. This ensures that the simulated coverage reflects both
current and residual effects of past distributions.</p>
</div>
<div class="section level3">
<h3 id="pyrethroid-resistance">Pyrethroid resistance<a class="anchor" aria-label="anchor" href="#pyrethroid-resistance"></a>
</h3>
<p><code>site_file$interventions$pyrethroid_resistance</code></p>
<p>For each site we include an estimated level of pyrethroid insecticide
resistance. This has been estimated by Tom Churcher and colleagues using
spatio-temporally distributed bioassay mortality data. This work is not
yet published. Therefore for attribution/citation and further
information on the methods used please contact Pete Winskill or Tom
Churcher.</p>
</div>
<div class="section level3">
<h3 id="itn-efficacy-parameters">ITN efficacy parameters<a class="anchor" aria-label="anchor" href="#itn-efficacy-parameters"></a>
</h3>
<p><code>site_file$interventions$dn0</code>
<code>site_file$interventions$rn0</code>
<code>site_file$interventions$gamman</code>
<code>site_file$interventions$rnm</code></p>
<p>Given an ITN type and level of pyrethroid insecticide resistance, we
can link to the corresponding estimates of the key ITN efficacy
parameters. These have been estimated by Ellie Sherrard-Smith <em>et
al</em><span class="citation"><sup><a href="#ref-sherrard2022">5</a></sup></span>. Please note that gamman is
provided in units of years here, these will need to be converted to days
for use in malariasimulaiton.</p>
</div>
</div>
<div class="section level2">
<h2 id="irs">IRS<a class="anchor" aria-label="anchor" href="#irs"></a>
</h2>
<div class="section level3">
<h3 id="irs-coverage">IRS coverage<a class="anchor" aria-label="anchor" href="#irs-coverage"></a>
</h3>
<p><code>site_file$interventions$irs_cov</code></p>
<p>As with ITNs, due to differences in the availability of data sources
the approach for countries within sub-Saharan Africa differs to
countries outside of sub-Saharan Africa:</p>
<div class="section level4">
<h4 id="within-sub-saharan-africa-1">Within sub-Saharan Africa<a class="anchor" aria-label="anchor" href="#within-sub-saharan-africa-1"></a>
</h4>
<p>The population at risk weighted mean IRS coverage estimates for each
site are taken from the malaria atlas project raster entitled:
“Interventions__202106_Africa_IRS_Coverage”<span class="citation"><sup><a href="#ref-MAP">3</a></sup></span>. Coverage
estimates are rescaled such that the country-level estimate of the
number of persons protected by IRS matches the number reported in the
world malaria report<span class="citation"><sup><a href="#ref-WMR">2</a></sup></span>.</p>
</div>
<div class="section level4">
<h4 id="outside-of-sub-saharan-africa-1">Outside of sub-Saharan Africa<a class="anchor" aria-label="anchor" href="#outside-of-sub-saharan-africa-1"></a>
</h4>
<p>IRS coverage is much more heterogeneous outside of SSA and data are
less systematically collected. As a result, there are strong assumptions
associated with the historical scale and magnitude of IRS campaigns. We
make the assumption that any reported persons protected by IRS (as
detailed by the world malaria report<span class="citation"><sup><a href="#ref-WMR">2</a></sup></span>) are targeted such that areas with
the highest baseline prevalence are prioritised first. IRS
coverage<br>
implemented up to a maximum usage of80% in each area, sequentially
working through the targeting until the reported total number of persons
protected have been allocated.</p>
</div>
</div>
<div class="section level3">
<h3 id="irs-insecticide">IRS insecticide<a class="anchor" aria-label="anchor" href="#irs-insecticide"></a>
</h3>
<p><code>site_file$interventions$irs_insecticide</code></p>
<p>It is assumed that a DDT-type insecticide is used prior to 2017,
after which there is a switch to an actellic-like insecticide.</p>
<p>Current available IRS insecticide options are: ddt, actellic,
bendiocarb, sumishield.</p>
</div>
<div class="section level3">
<h3 id="number-of-rounds-of-irs-per-year">Number of rounds of IRS per year<a class="anchor" aria-label="anchor" href="#number-of-rounds-of-irs-per-year"></a>
</h3>
<p><code>site_file$interventions$irs_spray_rounds</code></p>
<p>We assume a single IRS spray round per year.</p>
</div>
<div class="section level3">
<h3 id="irs-efficacy-parameters">IRS efficacy parameters<a class="anchor" aria-label="anchor" href="#irs-efficacy-parameters"></a>
</h3>
<p><code>site_file$interventions$ls_theta</code>
<code>site_file$interventions$ls_gamma</code>
<code>site_file$interventions$ks_theta</code>
<code>site_file$interventions$ks_gamma</code>
<code>site_file$interventions$ms_theta</code>
<code>site_file$interventions$ms_gamma</code></p>
<p>Given an IRS insecticide type we can link to the corresponding
estimates of the key IRS efficacy parameters. These have been estimated
by Ellie Sherrard-Smith <em>et al</em><span class="citation"><sup><a href="#ref-sherrard2018">6</a></sup></span>.</p>
</div>
<div class="section level3">
<h3 id="irs-households-sprayed">IRS households sprayed<a class="anchor" aria-label="anchor" href="#irs-households-sprayed"></a>
</h3>
<p>It is often helpful to convert the number of persons protected by IRS
into an estimate of the number of households covered. To aid this
conversion we have included country-levels estimates of the average
household size obtained from the UN<span class="citation"><sup><a href="#ref-UNHH">7</a></sup></span>.</p>
<p><code>site_file$interventions$hh_size</code></p>
</div>
<div class="section level3">
<h3 id="missing-years-1">Missing years<a class="anchor" aria-label="anchor" href="#missing-years-1"></a>
</h3>
<p>Available data on IRS coverage (via MAP<span class="citation"><sup><a href="#ref-MAP">3</a></sup></span> or the world malaria report<span class="citation"><sup><a href="#ref-WMR">2</a></sup></span>) will not
extend to the present year. Missing IRS coverage estimates to present
are filled assuming a constant, continuing level of coverage.</p>
</div>
</div>
<div class="section level2">
<h2 id="treatment">Treatment<a class="anchor" aria-label="anchor" href="#treatment"></a>
</h2>
<div class="section level3">
<h3 id="coverage">Coverage<a class="anchor" aria-label="anchor" href="#coverage"></a>
</h3>
<p><code>site_file$interventions$tx_cov</code></p>
<p>The population at risk weighted mean treatment coverage of an
effective antimalarial for each site are taken from the malaria atlas
project raster entitled: “Effective treatment with an Antimalarial drug
version 2020”<span class="citation"><sup><a href="#ref-MAP">3</a></sup></span>.</p>
</div>
<div class="section level3">
<h3 id="drug-type">Drug type<a class="anchor" aria-label="anchor" href="#drug-type"></a>
</h3>
<p><code>site_file$interventions$prop_act</code></p>
<p>We estimate the proportion of treatments that are with an ACT from
DHS StatCompiler data<span class="citation"><sup><a href="#ref-DHS">8</a></sup></span>, using the indicator: “Children who
took any ACT” (ID: ML_AMLD_C_ACT). For SSA estimates by year are
expanded by linear interpolation between data points and an assumption
of constant coverage after the most recent data point. We assume that
ACT coverage is zero before 2006, when the WHO recommendation was first
issued. For outside of SSA the DHS indicator is confounded by treatment
for Plasmodium vivax, and we therefore assume the mean values by year
from data within SSA.</p>
</div>
<div class="section level3">
<h3 id="drug-provider">Drug provider<a class="anchor" aria-label="anchor" href="#drug-provider"></a>
</h3>
<p><code>site_file$interventions$prop_public</code></p>
<p>We include an estimate of the proportion of treatments that are from
the public sector <code>prop_public</code>. This is useful for costing.
We use the DHS StatCompiler<span class="citation"><sup><a href="#ref-DHS">8</a></sup></span> indicator “Children with fever for
whom advice or treatment was sought, the source was a public sector
facility” (ID: ML_FEVA_C_PUB). We assume a constant proportion over time
by country, estimated as the mean from all country survey estimates
since 2010. For countries without survey data, we assume the median
across all estimates.</p>
</div>
</div>
<div class="section level2">
<h2 id="seasonal-malaria-chemoprevention-smc">Seasonal malaria chemoprevention (SMC)<a class="anchor" aria-label="anchor" href="#seasonal-malaria-chemoprevention-smc"></a>
</h2>
<div class="section level3">
<h3 id="smc-coverage">SMC coverage<a class="anchor" aria-label="anchor" href="#smc-coverage"></a>
</h3>
<p><code>site_file$interventions$smc_cov</code></p>
<p>Historical SMC implementation and coverage estimates are fragmented.
We identify historical SMC implementation areas from maps presented by
both Access SMC<span class="citation"><sup><a href="#ref-access_SMC">9</a></sup></span> and more recently SMC
alliance<span class="citation"><sup><a href="#ref-SMC_alliance">10</a></sup></span>. We assume a linear
increase in coverage post implementation initiation up to a maximum of
80% to capture an increasing number of smaller sub-national units being
targeted over time.</p>
</div>
<div class="section level3">
<h3 id="smc-drug">SMC drug<a class="anchor" aria-label="anchor" href="#smc-drug"></a>
</h3>
<p><code>site_file$interventions$smc_drug</code></p>
<p>We assume that SP-AQ is used for SMC. This is currently the only
available drug option.</p>
</div>
<div class="section level3">
<h3 id="number-of-smc-rounds-delivered-annualy">Number of SMC rounds delivered annualy<a class="anchor" aria-label="anchor" href="#number-of-smc-rounds-delivered-annualy"></a>
</h3>
<p><code>site_file$interventions$smc_n_rounds</code></p>
<p>We assumed that historical SMC is delivered over 4 rounds
<code>smc_n_rounds</code>.</p>
</div>
<div class="section level3">
<h3 id="smc-age-range">SMC age range<a class="anchor" aria-label="anchor" href="#smc-age-range"></a>
</h3>
<p><code>site_file$interventions$smc_min_age</code>
<code>site_file$interventions$smc_max_age</code></p>
<p>We assume SMC is delivered to children aged between 3 months and 5
years.</p>
</div>
</div>
<div class="section level2">
<h2 id="rtss-vaccine">RTS,S vaccine<a class="anchor" aria-label="anchor" href="#rtss-vaccine"></a>
</h2>
<p><code>site_file$interventions$rtss_cov</code></p>
<p>We include historical RTS,S coverage that has occurred as part of the
MVIP implementation trial, sub-nationally in Malawi, Ghana and Kenya.
The spatial distribution is informed from an MVIP briefing
presentation<span class="citation"><sup><a href="#ref-MVIP">11</a></sup></span></p>
</div>
<div class="section level2">
<h2 id="perennial-malaria-chemoprevention-pmc-">Perennial malaria chemoprevention (PMC).<a class="anchor" aria-label="anchor" href="#perennial-malaria-chemoprevention-pmc-"></a>
</h2>
<p>This intervention has been known in the past as intermittent
preventative treatment of infants (IPTi).</p>
<div class="section level3">
<h3 id="pmc-coverage">PMC coverage<a class="anchor" aria-label="anchor" href="#pmc-coverage"></a>
</h3>
<p><code>site_file$interventions$pmc_cov</code></p>
<p>Due to the very limited (non-trial setting) implementation of PMC
historically, we assume 0 coverage.</p>
</div>
<div class="section level3">
<h3 id="pmc-drug">PMC drug<a class="anchor" aria-label="anchor" href="#pmc-drug"></a>
</h3>
<p><code>site_file$interventions$pmc_drug</code></p>
<p>We assume PMC would be implemented with SP. This is currently the
only available drug option.</p>
</div>
</div>
<div class="section level2 unnumbered">
<h2 class="unnumbered" id="citations">Citations<a class="anchor" aria-label="anchor" href="#citations"></a>
</h2>
<div id="refs" class="references csl-bib-body" entry-spacing="0" line-spacing="2">
<div id="ref-bertozzi" class="csl-entry">
<div class="csl-left-margin">1. </div>
<div class="csl-right-inline">Bertozzi-Villa, A. <em>et al.</em> <a href="https://doi.org/10.1038/s41467-021-23707-7" class="external-link">Maps and metrics of
insecticide-treated net access, use, and nets-per-capita in africa from
2000-2020</a>. <em>Nature Communications</em> <strong>12</strong>, 1–12
(2021).</div>
</div>
<div id="ref-WMR" class="csl-entry">
<div class="csl-left-margin">2. </div>
<div class="csl-right-inline">World Health Organization. <em>World malaria
report</em>. (2024).</div>
</div>
<div id="ref-MAP" class="csl-entry">
<div class="csl-left-margin">3. </div>
<div class="csl-right-inline">
<a href="https://malariaatlas.org/" class="external-link">Malaria atlas project</a>.</div>
</div>
<div id="ref-alliance" class="csl-entry">
<div class="csl-left-margin">4. </div>
<div class="csl-right-inline">
<a href="https://https://allianceformalariaprevention.com/itn-dashboards/mass-campaign-tracker/" class="external-link">Alliance
for malaria prevention</a>.</div>
</div>
<div id="ref-sherrard2022" class="csl-entry">
<div class="csl-left-margin">5. </div>
<div class="csl-right-inline">Sherrard-Smith, E. <em>et al.</em> <a href="https://doi.org/10.1016/S2542-5196(21)00296-5" class="external-link">Optimising the
deployment of vector control tools against malaria: A data-informed
modelling study</a>. <em>The Lancet Planetary Health</em>
<strong>6</strong>, e100–e109 (2022).</div>
</div>
<div id="ref-sherrard2018" class="csl-entry">
<div class="csl-left-margin">6. </div>
<div class="csl-right-inline">Sherrard-Smith, E. <em>et al.</em> <a href="https://doi.org/10.1038/s41467-018-07357-w" class="external-link">Systematic review of
indoor residual spray efficacy and effectiveness against plasmodium
falciparum in africa</a>. <em>Nature Communications</em>
<strong>9</strong>, 4982 (2018).</div>
</div>
<div id="ref-UNHH" class="csl-entry">
<div class="csl-left-margin">7. </div>
<div class="csl-right-inline">United Nations. <a href="https://www.un.org/development/desa/pd/data/household-size-and-composition" class="external-link">Household
size and composition</a>.</div>
</div>
<div id="ref-DHS" class="csl-entry">
<div class="csl-left-margin">8. </div>
<div class="csl-right-inline">USAID. <a href="https://dhsprogram.com/" class="external-link">The
DHS program</a>.</div>
</div>
<div id="ref-access_SMC" class="csl-entry">
<div class="csl-left-margin">9. </div>
<div class="csl-right-inline">
<a href="https://www.access-smc.org/" class="external-link">Access SMC</a>.</div>
</div>
<div id="ref-SMC_alliance" class="csl-entry">
<div class="csl-left-margin">10. </div>
<div class="csl-right-inline">
<a href="https://www.smc-alliance.org/" class="external-link">SMC alliance</a>.</div>
</div>
<div id="ref-MVIP" class="csl-entry">
<div class="csl-left-margin">11. </div>
<div class="csl-right-inline">World Health Organization. <a href="https://www.givewell.org/files/DWDA%202009/PATH/WHO_WHO_Malaria_Vaccine_Implementation_Program_Briefing_2021.pdf" class="external-link">MVIP
briefing</a>.</div>
</div>
</div>
</div>
  </main><aside class="col-md-3"><nav id="toc" aria-label="Table of contents"><h2>On this page</h2>
    </nav></aside>
</div>



    <footer><div class="pkgdown-footer-left">
  <p>Developed by Pete Winskill.</p>
</div>

<div class="pkgdown-footer-right">
  <p>Site built with <a href="https://pkgdown.r-lib.org/" class="external-link">pkgdown</a> 2.1.1.</p>
</div>

    </footer>
</div>





  </body>
</html>
